Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-850 SC vs IM in Healthy Adults
NCT02313155Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 2014
- Primary completion
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of TAK-850 in influenza, sponsored by Takeda. Started Dec 2014; status: completed.
02
Drugs
TAK-850
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02313155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313155.